Filing Flows › Pulse Biosciences (PLSE) › Q2 2026
Pulse Biosciences (PLSE) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 6, 2026
Pulse Biosciences (PLSE) reported revenue of $434K for the second quarter 2026 (Q2 2026) and +8% from the quarter before.
Pulse Biosciences, Q2 2026: revenue $434K, net loss $24.7M, operating cash flow −$18.7M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $434K | +8% | — |
| Operating profit | −$25.3M | — | — |
| Net earnings | −$24.7M | — | — |
| Operating cash flow | −$18.7M | — | — |
What changed
Revenue was $434K in Q2 2026, up 8% from the previous quarter.
Operating costs exceeded revenue by $25.3M, an operating margin of -5823.0%. The quarter ended with a net loss of $24.7M, wider than the previous quarter's $18.6M loss.
Operating cash flow was −$18.7M. Non-cash charges added back $254K of depreciation and amortization and $5.0M of share-based compensation. Capital expenditures of $90K exceeded it, leaving free cash flow of −$18.8M.
Questions
What was Pulse Biosciences' revenue in the second quarter 2026?
Pulse Biosciences (PLSE) reported revenue of $434K for the second quarter 2026 (Q2 2026) and +8% from the quarter before.
Source: Pulse Biosciences 10-Q on SEC EDGAR.